Event News & Resources
Neuro-Bio Ltd begins an exciting new chapter in the heart of Oxford
After 13 years, Neuro-Bio has recently relocated from Culham Campus, Abingdon to Central Oxford. Culham Campus has been the setting for many important milestones in Neuro-Bio’s journey, and we are immensely grateful to everyone at the Campus who has supported us along...
Neuro-Bio Ltd begins an exciting new chapter in the heart of Oxford
After 13 years, Neuro-Bio has recently relocated from Culham Campus, Abingdon to Central Oxford. Culham Campus has been the setting for many important milestones in Neuro-Bio’s journey, and we are immensely grateful to everyone at the Campus who has supported us along...
Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
Neuro-Bio was featured in a SelectScience webinar, “How Synthetic Binders Are Transforming Diagnostics and Molecular Biology.” The webinar explored how synthetic binders are providing effective alternatives where traditional antibodies can fall short. Baroness Susan...
New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
We are pleased to announce the publication of our latest paper, “Evaluating the Efficacy of Monoclonal Antibodies Against a Bioactive Peptide Involved in Alzheimer’s Disease: A Methodological Approach.” The paper outlines a methodological framework for assessing...
Neuro-Bio’s first paper of 2026 has been published!
We’re proud to announce that our first paper of the year has been published! “Therapeutic antagonism of a key toxin driving Alzheimer’s disease: Comparison of a peptide variant and small molecule.” Congratulations to all the authors involved in this important work and...
Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
We were delighted to welcome Jo Hayman to visit Neuro-Bio to spend time with Baroness Greenfield and other members of the team. Jo met with our CEO & Founder, Baroness Susan Greenfield, for a series of discussions, including preparations for a panel event...
CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
A brilliant and energising exchange of ideas this week as Baroness Greenfield (CEO) and Dr Sara Garcia Ratés (CSO) met with the Dalloway Partners team - Vanessa Collomar, Helen James and Ella Mamelok. We were proud to share the Neuro-Bio team’s vision and 3-year...